These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 7907752)
1. Transparietal diffusion of polidocanol: Potential complication of sclerotherapy? Ramelet AA; Bossart S Phlebology; 2023 Dec; 38(10):698-699. PubMed ID: 37644640 [No Abstract] [Full Text] [Related]
2. Response to - Letter to the editor 'Transparietal diffusion of polidocanol: Potential complication of sclerotherapy?'. Kang M; Parsi K Phlebology; 2023 Dec; 38(10):700. PubMed ID: 37821217 [No Abstract] [Full Text] [Related]
3. Reversible ischaemic neurological deficit after sclerotherapy of varicose veins. Van der Plas JP; Lambers JC; Van Wersch JW; Koehler PJ Lancet; 1994 Feb; 343(8894):428. PubMed ID: 7905592 [No Abstract] [Full Text] [Related]
4. Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Fisher DA Dermatol Surg; 2000 Nov; 26(11):1082. PubMed ID: 11096404 [No Abstract] [Full Text] [Related]
5. Stroke after varicose vein foam injection sclerotherapy. Forlee MV; Grouden M; Moore DJ; Shanik G J Vasc Surg; 2006 Jan; 43(1):162-4. PubMed ID: 16414404 [TBL] [Abstract][Full Text] [Related]
6. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology. Rabe E; Pannier F Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702 [TBL] [Abstract][Full Text] [Related]